NasdaqGS:AMGNBiotechs
Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California
Amgen (AMGN) recently announced plans to invest $600 million for a new science and innovation center at its headquarters, demonstrating a robust commitment to its U.S. operations. While the company's recent price movement was largely flat over the last quarter, this investment aligns with their broader strategy of enhancing research capabilities. During the same period, Amgen also received positive regulatory updates for Repatha® and reported solid earnings growth, providing a counterbalance...